Altamira Therapeutics Ltd (NASDAQ:CYTO) shares are surging after announcing preclinical efficacy data from testing its Bentrio nasal spray against the omicron…
Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to developing therapeutics that address important unmet medical needs, announced today that it has entered into an agreement for the marketing and